Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_assertion description "[We found that a large fraction of neuroblastoma biopsies, independently from the clinical stage and degree of tumor cell differentiation, expressed significant levels of NY-ESO-1 as assessed by reverse transcription-PCR and immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_assertion evidence source_evidence_literature NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_assertion SIO_000772 14583496 NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_assertion wasDerivedFrom befree-20140225 NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_assertion wasGeneratedBy ECO_0000203 NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP390961.RAB-GtHMrR9JLB24KoUZaKrM3eM5KKtD9mPHeek_D6Ib0130_provenance.